Filing metadata

Accession number
0001104659-22-035171
Form type
Form 5
Filer
POINT Biopharma Global Inc.
CIK
CIK 1811764
Filed
Mar 17, 2022
Reporting period
Dec 31, 2021
Description
Annual insider statement

Explore SEC Filings Hub